Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-307,723
Closed -$41.1M 67
2017
Q1
$41.1M Sell
307,723
-144,264
-32% -$18.4M 2.67% 11
2016
Q4
$45.3M Sell
451,987
-145,651
-24% -$14.2M 3.91% 7
2016
Q3
$56.4M Buy
597,638
+295,331
+98% +$24.9M 4.48% 6
2016
Q2
$24.2M Buy
302,307
+85,713
+40% +$6.65M 2.31% 18
2016
Q1
$15.7M Sell
216,594
-141,318
-39% -$10.5M 1.61% 24
2015
Q4
$38.8M Sell
357,912
-255,686
-42% -$28.5M 2.9% 16
2015
Q3
$67.7M Buy
613,598
+448,603
+272% +$50.3M 5.13% 5
2015
Q2
$17.2M Buy
+164,995
New +$17.1M 1.41% 27
2014
Q1
Sell
-448,998
Closed -$22.7M 61
2013
Q4
$22.7M Buy
+448,998
New +$19.5M 2.81% 9

Other funds holding INCY

Redmile Group's INCY Position: Q2 2017 in Review

Redmile Group sold out of Incyte (INCY) in Q2 2017, closing a stake of 307,723 shares — an estimated $41.1M sold.

Redmile Group first reported a position in INCY in Q4 2013 and held it in 9 quarters. The position peaked at $67.7M in Q3 2015. 493 funds tracked by Wall St. Rank hold INCY as of Q2 2017.

  • Redmile Group reported no remaining Incyte position as of Q2 2017 after selling out during the quarter.
  • Redmile Group sold 307,723 Incyte shares in Q2 2017, an estimated $41.1M.
  • Redmile Group first reported a position in Incyte in Q4 2013 and held it in 9 quarters.
  • Redmile Group's Incyte position peaked at $67.7M in Q3 2015.
  • 493 funds tracked by Wall St. Rank held Incyte as of Q2 2017.

Based on Redmile Group's 13F filing for Q2 2017, filed 15 Aug 2017.